Clinical Trial Update: Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase I study evaluating a melphalan, bendamustine, and carfilzomib regimen for autologous stem cell transplantation in multiple myeloma; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• Carfilzomib (carfilzomib)
• Melphalan (Melphalan)

Snippet

Sponsor: Corewell Health West | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2024-07-26